• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    Celgene Corporation (CELG)

    -NasdaqGS
    122.36 Down 1.76(1.42%) 4:00PM EST
    |After Hours : 123.02 Up 0.66 (0.54%) 5:30PM EST
    Add to Portfolio
    Prev Close:124.12
    Open:122.91
    Bid:122.74 x 100
    Ask:124.10 x 1000
    1y Target Est:125.17
    Beta:2.02
    Next Earnings Date:29-Jan-15CELG Earnings announcement
    Day's Range:122.04 - 124.57
    52wk Range:66.85 - 124.60
    Volume:3,475,792
    Avg Vol (3m):5,197,480
    Market Cap:97.73B
    P/E (ttm):64.10
    EPS (ttm):1.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CELG

    Comparison

    Symbol% ChgMkt Cap
    CELGDown 1.42%97.73B
    JNJDown 0.17%285.76B

    Key Statistics

    Forward P/E (1 yr):25.13
    P/S (ttm):13.50
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :3.69
    Quarterly EPS Est (Dec-14) :0.99
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):1.25

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback